Drugs / Glucoraphanin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01437501 | Oct 2011 → Jan 2012 | — | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07360977 | Jan → May 2026 overdue | Parkinson disease, neuromuscular disease, relapsing-remitting multiple sclerosis | IRCCS Centro Neurolesi Bonino Pulejo | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glucoraphanin | “Broccoli Sprout Extract Beverage: 600 micromole glucoraphanin and 40 micromole sulforaphane dissolved in 100 mL dilute pineapple and lime juice daily for 84 days.” NCT01437501 ↗1“In particular, from glucoraphanin (GRA) the ITC sulforaphane (SFN) is obtained.” NCT07360977 ↗ |
| Known as | GRA | “In particular, from glucoraphanin (GRA) the ITC sulforaphane (SFN) is obtained.” NCT07360977 ↗ |